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Abstract
The precise spatio-temporal dynamics of protein activity are often critical in determining cell 
behaviour, yet for most proteins they remain poorly understood; it remains difficult to manipulate 
protein activity at precise times and places within living cells. Protein activity has been controlled 
by light, through protein derivatization with photocleavable moieties1 or using photoreactive 
small molecule ligands2. However, this requires use of toxic UV wavelengths, activation is 
irreversible, and/or cell loading is accomplished via disruption of the cell membrane (i.e. through 
microinjection). We have developed a new approach to produce genetically-encoded photo-
activatable derivatives of Rac1, a key GTPase regulating actin cytoskeletal dynamics3,4. Rac1 
mutants were fused to the photoreactive LOV (light oxygen voltage) domain from phototropin5,6, 
sterically blocking Rac1 interactions until irradiation unwound a helix linking LOV to Rac1. 
Photoactivatable Rac1 (PA-Rac1) could be reversibly and repeatedly activated using 458 or 473 
nm light to generate precisely localized cell protrusions and ruffling. Localized Rac activation or 
inactivation was sufficient to produce cell motility and control the direction of cell movement. 
Myosin was involved in Rac control of directionality but not in Rac-induced protrusion, while 
PAK was required for Rac-induced protrusion. PA-Rac1 was used to elucidate Rac regulation of 
RhoA in cell motility. Rac and Rho coordinate cytoskeletal behaviours with seconds and 
submicron precision7,8. Their mutual regulation remains controversial9, with data indicating that 
Rac inhibits and/or activates Rho10,11. Rac was shown to inhibit RhoA in living cells, with 
inhibition modulated at protrusions and ruffles. A PA-Rac crystal structure and modelling revealed 
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LOV-Rac interactions that will facilitate extension of this photoactivation approach to other 
proteins.
Recent NMR studies by Harper et al. revealed the mechanism of a protein light switch in 
Avena sativa Phototropin16,12: a flavin-binding LOV2 domain interacts with a C-terminal 
helical extension (Jα) in the dark. Photon absorption leads to formation of a covalent bond 
between Cys450 and the flavin chromophore, causing conformational changes that result in 
dissociation and unwinding of the Jα helix. We fused the complete LOV2-Jα sequence 
(404–547) to the N-terminus of a constitutively active Rac1, anticipating that the LOV 
domain in its closed conformation would block the binding of effectors to Rac1, and that 
light-induced unwinding of the Jα helix would release steric inhibition, leading to Rac1 
activation (Fig. 1a). Sampling of different junctional sequences in pull down assays revealed 
that connecting Leu546 of LOV2-Jα to Ile4 of Rac1 led to substantial reduction in Rac1 
binding to its effector PAK (Fig. 1b and Supplementary Fig. S1a). To ensure that the 
photoactivatable Rac1 would induce no dominant negative effects and that its activity would 
not be subject to upstream regulation, mutations were introduced to abolish GTP hydrolysis 
and diminish interactions with nucleotide exchange factors, guanine nucleotide dissociation 
inhibitors (Q61L) and GTPase activating proteins (E91H and N92H) (Supplementary: Fig. 
S2 and “Characterization of Rac1 constructs”). This resulted in the photoactivatable 
analogue of Rac1 (PA-Rac1) used in the following studies. Pull down assays showed that 
PA-Rac1 has greatly reduced affinity for its effector protein PAK in the dark, as does a PA-
Rac1 construct containing a light-insensitive LOV2 mutation (C450A)13. Effector binding 
was restored in a PA-Rac1 construct containing a LOV2 mutant (I539E)14 that mimics the 
unfolded ‘lit state’ (Fig. 1b and Supplementary Fig. S1b). Isothermal titration experiments 
indicated that the dark and lit state mutants of PA-Rac1 differed 10-fold in effector binding 
(200 nM versus 2 µM) (Supplementary Fig. S3 and Table S1), with lit state effector affinity 
similar to that of native Rac15.
Activation of PA-Rac1 was examined in HeLa cells expressing a YFP fusion of PA-Rac1 to 
gauge expression level. The cells remained quiescent when illuminated with wavelengths 
longer than flavin absorbance (515, 568 or 633 nm, data not shown), but within seconds 
after switching to 458 nm, lamellipodial protrusions and membrane ruffles appeared around 
the cell edges (Fig. 1c and Supplementary Movie S1). To show that this effect was due to 
PA-Rac1, kymograms were used to quantify maximum protrusion length; Irradiation of PA-
Rac1 elicited protrusions that were four times as long as those seen in cells expressing either 
LOV domain alone or the light-insensitive PA-Rac1-C450A mutant (Supplementary Fig. 
S4). An important advantage of PA-Rac1 is its ability to precisely control the subcellular 
location of Rac activation. We first examined this in mouse embryo fibroblasts (MEF) stably 
expressing PA-Rac1, and cultured without serum to minimize cell activity prior to 
irradiation. Irradiation of 20 µm spots at the cell edge generated large protrusions clearly 
localized next to the point of irradiation (Fig. 1d and Supplementary Movie S2). Repeated 
irradiation led first to ruffles and then to protrusion. YFP-actin, YFP-PAK, and YFP-Arp3 
revealed actin polymerization at the edge of the Rac-induced protrusions with associated 
translocation of downstream effectors, and induction of localized PAK phosphorylation was 
shown by immunostaining (Supplementary Fig S5,6 and Movies S3,4). Movement of a laser 
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spot to different positions led to cessation of ruffling or protrusion at the initial irradiation 
position and new activities appearing where the laser spot was brought to rest (HeLa cells, 
Supplementary Movie S5), demonstrating reversible activation. In MEF cells, more prone to 
movement than HeLa, complex shape changes were produced by ‘painting’ the cell with the 
laser spot (Supplementary Movie S6). The area of protrusions in MEF cells was dependent 
on light dosage, indicating the valuable ability to control the level of Rac1 activation 
(Supplementary Fig. S7). PA-Rac1 diffusion was analyzed using FRAP (fluorescence 
recovery after photobleaching) and using PA-Rac1 tagged with photoactivatable GFP16 
(Supplementary Fig. S8 and Movies S7,8), indicating that PA-Rac1 diffuses more slowly 
than cytosolic proteins, likely because it is membrane bound (10 µm spot, FRAP D=0.55 
µm2/s or t1/2= 12.1s; PA-GFP t1/2=14.6 s). The half life of dark recovery for PA-Rac1 was 
determined to be 43s at room temperature. Simulation using this value indicated that, for 
two adjacent 10-µm spots, the unirradiated spot will achieve at most 7.5% the activation of 
the irradiated region (Supplementary Fig. S8c). Together these studies validate PA-Rac1 as 
a robust, genetically encoded and reversible caged protein effective in living cells.
We used PA-Rac1 to ask whether localized Rac activation is sufficient to specify cell 
polarity. In MEF cells, activating Rac1 at one spot near the cell edge not only generated 
protrusion locally, but also produced retraction on the opposite side of the cell (Fig. 2a and 
Supplementary Movie S9). To test whether this cross-cell coordination was due to a gradient 
of Rac1 activity, we fused the LOV domain to a dominant negative mutant of Rac1 using the 
same linkage as in PA-Rac1. Irradiation of this PA-Rac1-T17N led to nearby retraction 
rather than protrusion, and now generated protrusion in other areas of the cell (Fig 2a and 
Supplemental Movies S10,11). The ability of Rac1 alone to control polarized movement was 
confirmed by repeated irradiation at the cell edge, which could be used to produce prolonged 
cell movement by generating consistent coordinated extension and retraction (MEF cells: 
Fig. 2b and Supplemental Movie S12; HEK293 cells: Supplemental Movie S13). In contrast 
to MEF and HEK293 cells, HeLa cells showed localized protrusion but could not be induced 
to retract or move simply by activating Rac (Supplemental Movie S3), indicating that Rac-
induced motility is subject to modulation by other pathways.
PA-Rac1 enabled control of Rac1 activity without the prior cellular compensation seen with 
other techniques, i.e. mutation or altered expression. Using this advantage, we examined the 
role of myosin, a key mediator of actin-based contractility, in Rac-induced motility. Global 
inhibition of myosin activity using the myosin ATPase inhibitor blebbistatin or the myosin 
light chain kinase inhibitor ML-7 strongly affected Rac’s ability to specify the direction of 
cell movement, but minimally affected Rac-induced protrusion (Fig. 2c,d). Myosin may 
mediate Rac’s control of directionality through induction of tail retraction17, contraction of 
the cell cortex to direct protrusive force18, or coupling of actin to adhesions differently at 
the front and rear19. In contrast, inhibition of PAK was found to strongly affect Rac-induced 
protrusion (Supplementary Fig. S9). Inhibition of the Rho-activated kinase ROCK using 
Y27632 suggested a role for ROCK in Rac-induced protrusion, but these results must be 
interpreted with caution due to known off-target effects20.
Where and how Rac regulates Rho in vivo remains largely unknown; this was examined by 
using PA-Rac1 together with a RhoA biosensor8. Localized activation of Rac1 led to 
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immediate inhibition of RhoA, and this inhibition spread outward from the irradiated spot 
(Fig. 3a and Supplementary Movie S14). This was not simply an artifact of biosensor 
photobleaching, as irradiating the photo-inactive C450M mutant (Fig. 2c) of PA-Rac1 led to 
localized biosensor photobleaching and recovery, but no prolonged local inhibition or wave 
of inhibition (Fig. 3a). There were striking differences between constitutive MEF 
protrusions and protrusions induced by pulsed PA-Rac1 irradiation. In contrast to 
constitutive protrusions, RhoA activity was greatly reduced in protrusions induced by PA-
Rac (Fig. 3b). Inhibition of RhoA appears to be compartmentalized or controlled kinetically 
when Rac is activated in the context of normal motility, as both active Rac and active Rho 
are seen at the leading edge7,8,21. PA-Rac activation led to large ruffles moving from the 
site of irradiation rearwards towards the nucleus (Supplementary Movie S15), suggesting 
that Rac regulates rearwards membrane flow. In control experiments, irradiation of cells 
expressing the photo-inactive C450M mutant did not produce polarized ruffling or show 
reduced RhoA activity (data not shown).
To understand the structural basis of the PA-Rac1 switch for future application to other 
proteins, we performed Rosetta structure prediction simulations22 on several LOV2-Rac1 
constructs, and determined high-resolution crystal structures of photo-active and inactive 
PA-Rac1 in the dark state. The crystal structures confirmed that the LOV domain occludes 
effector binding in the dark state (Fig. 4a and Supplementary Table S2). LOV-Jα adopted a 
closed conformation that superimposes with the recently published structure of isolated 
LOV-Jα23. In the conformational ensemble predicted by simulations of the dark state, the 
effector binding site of Rac was sterically blocked by the LOV domain in a majority of the 
low energy models (Supplementary Tables S3–5 and Figs. S10–13). Consistent with pull 
down assays (Fig. 1b and Supplementary Fig. S1a), adding or removing even one residue 
from the connection between LOV and Rac resulted in conformational ensembles with 
exposed effector binding sites. In the dark state, Rac was seen to form an extensive interface 
with the LOV domain (Fig. 4b), occluding Rac binding interactions. Given the substantial 
structural similarity between Rac1 and Cdc42, we hypothesized that the LOV domain could 
also be used to cage Cdc42. However, the linkage used for PA-Rac1 failed to reduce Cdc42 
binding to PAK (Fig. 4c and Supplementary Fig. S1d). Using the PA-Rac1 crystal structure 
as a template, a model was built of the Cdc42-LOV dark state. At the interface between Rac 
and LOV a hydrophobic cluster is formed between residues Phe37 and Trp56 from Rac and 
Leu422, Pro423, Ile428, Tyr508 and Leu546 from LOV. Consistent with this being a weak, 
non-evolved interaction, most of the hydrogen bonding potential at the Rac-LOV interface is 
satisfied by buried and partially buried water molecules instead of inter-domain hydrogen 
bonds (Fig 4b). This interface model was used to identify a mutation to Cdc42, F56W at the 
Rac-LOV interface, that was predicted to stabilize the dark state. Pull down assays showed 
that this mutation substantially improves dark state inhibition of PAK binding, and produces 
differential affinity for Cdc42 effector in the dark versus the lit state (Fig. 4d). In living 
cells, irradiation of the mutated PA-Cdc42 led to production of filopodia and in some cases 
protrusions and/or ruffles, consistent with Cdc42 induction of filopodia and activation of 
Rac24 (Supplementary Fig. S14 and Supplementary Movie S16). These results argue that 
PA-Rac1 can serve as a blueprint for engineering other caged GTPases.
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In summary, we have engineered genetically-encoded photoactivatable Rac1 analogs that 
enable precise spatial and temporal control of Rac activity in live cells, with reversible 
activation at 458 or 473 nm. Localized Rac activation or deactivation was sufficient to 
generate polarized cell movement. Rac could be activated without cellular compensation, 
enabling us to probe the role of myosin and PAK in Rac-mediated motility. Spatially-
regulated Rac inhibition of Rho was demonstrated in living cells. Structural studies indicate 
that a non-evolved interaction at the Rac-LOV interface can be engineered to cage other 
GTPases. This study and other recent work25–28 show that coupling genetically encoded 
light-modulated domains to other proteins provides a versatile new route to control protein 
activities in living cells.
METHODS SUMMARY
Imaging experiments were conducted on an Olympus FluoView 1000 laser scanning 
confocal microscope and an Olympus IX81-ZDC inverted microscope. Biosensor imaging 
was performed as previously described8,29. Simultaneous biosensor imaging and activation 
of PA-Rac was achieved using a MAG Biosystems FRAP-3D add-on (Photometrics) for 
galvanometer control of laser position. Detailed materials and methods are included in the 
supplementary information.
Supplementary Material
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Figure 1. Engineering and in vivo characterization of a photoactivatable Rac1 (PA-Rac1)
a, Cartoon representation of PA-Rac1 design. b, Pulldown of PA-Rac1 constructs with PAK 
in the dark. Truncations of LOV and Rac at their linkage point were tested: 539–547, in red 
= terminal amino acid of Jα; 2–4, in green = first residue of Rac1. 546−4 showed the 
strongest inhibition; PA-Rac1 = 546−4, Q61L/E91H/N92H; -C450A, light-insensitive 
mutant; -I539E, lit state mutant. Pulldown by constitutively active (Q61L) and dominant 
negative (T17N) mutants are included for comparison with PA-Rac1. c, Whole cell 
irradiation of a HeLa cell expressing PA-Rac1. (minutes after irradiation, DIC, short axis of 
box = 20 µm). d, Spatial control of Rac1 activity. A 20-µm circle (red) was irradiated every 
60 seconds in serum-starved MEF cells. Solid line = cell border at time 0, dotted line = 10 
minutes after initial light pulse. Little movement of the cell border was detected, except 
adjacent to the point of irradiation. The kymograph (taken using white line, 20 µm), shows 
the initial formation of ruffles after each pulse, followed by protrusion (arrowheads = 
irradiation pulses).
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Figure 2. Localized activation or inactivation of PA-Rac1 induces myosin-dependent migration
a, Protrusion/retraction map after a single pulse of activating illumination. MEFs expressing 
PA-Rac1 (left) generated protrusions at the site of irradiation (red) and retraction at the 
opposite side of the cell (blue) (in all 50 cells studied). Irradiation of the dominant 
negativeT17N mutant of PA-Rac1 (right) produced retraction near the point of irradiation, 
with protrusion in area(s) other than the site of irradiation (in all 25 cells studied). b, 
Repeated activation of PA-Rac1 at the cell edge induces directional migration. (MEF, 2-
minute intervals, avg. 0.8 microns/pulse, n = 6). c, Localized activation of PA-Rac1 in the 
presence of ML-7 (MLCK inhibitor, 1 µM), Blebbistatin (Myosin II ATPase inhibitor, 1 
µM), or Y-27632 (ROCK inhibitor, 10 µM). Protrusions analyzed as in panel a. d, Effect of 
myosin or ROCK inhibition on the ability of Rac1 to specify the direction of movement. The 
cosine of the angle between two lines (from the irradiation spot to the cell centroid at time 0, 
from the centroid at time 0 to the centroid at the end of the experiment) indicated how much 
the cell deviates from the direction specified by local irradiation. (panels c and d, n > 25; 
means +/− 95% confidence intervals; throughout figure 3 irradiation at 458 nm, Ø = 10 µm).
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Figure 3. Inhibition of RhoA by PA-Rac1
a, HeLa cells expressing RhoA biosensor and either PA-Rac1 or its C450M photo-inactive 
mutant, illuminated in a 10-µm circle with a single pulse of 473 nm light. Changes in the 
FRET efficiency (Ecorr) of the RhoA biosensor, indicative of RhoA activation, are shown in 
pseudocolor and as plots of average FRET efficiency within the irradiated circle (blue) and a 
nearby circle (red). In the PA-Rac1 cells, the irradiated spot showed bleaching of the 
biosensor followed by a relatively constant level of reduced RhoA activity. The nearby spot 
showed no bleaching, but a gradual decrease in RhoA activity reaching the low level 
achieved in the irradiated spot (n = 3 cells). In the control cells (C450M), the biosensor 
returned to near initial activation readouts after bleaching, and no change was seen in the 
nearby spot (n =3 cells). b, RhoA activation in constitutive pseudopods8,21 versus 
pseudopods induced by PA-Rac1 (473 nm, 20-µm circle shown, Supplemental Movie S15). 
The bar graph (c) shows the percent increase in biosensor FRET/CFP ratio in the region 1 
micron from the cell edge versus the mean of the flat region at the left of the line scan. 
(means +/− 95% confidence intervals, 18 lines from 6 cells per bar).
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Figure 4. Crystallization and structural modelling of PA-Rac1
a, Dark state crystal structure of PA-Rac1. Blue = LOV domain, red = Jα helix, and green = 
Rac1. b, Interacting residues at the LOV-Rac interface (arrow in panel a), including Trp56. 
c, Mutating Cdc42 to include the Trp involved in stabilizing the LOV2-Rac1 interaction 
substantially improved LOV inhibition of Cdc42. Lane 1, PA-Cdc42; linking LOV to Cdc42 
using the same truncations that produced good inhibition for Rac does not inhibit Cdc42-
PAK binding. Lane 2, PA-Cdc42-CRIB; covalently linking the CRIB domain of PAK to 
PA-Cdc42 blocks PAK binding. Lane 3, PA-Cdc42-F56W; introduction of the tryptophan 
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substantially improves LOV inhibition of Cdc42 binding to PAK. Lane 4, lit state mutant of 
PA-Cdc42-F56W, showing that Cdc42 inhibition is sensitive to the lit/dark state of the LOV 
domain. Supplemental Movie S16 and Fig. S14 demonstrate the ability of PA-Cdc42-F56W 
to produce filopodia and protrusions in living cells.
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